India, July 17 -- While reporting financial results for the second quarter on Wednesday, Abbott Laboratories (ABT) provided adjusted earnings guidance for the third quarter and raised its adjusted earnings outlook for the full-year 2025.
For the third quarter, Abbott projects adjusted earnings in a range of $1.28 to $1.32 per share.
On average, 22 analysts polled expect the company to report earnings of $1.33 per share for the quarter. Analysts' estimates typically exclude special items. Looking ahead to fiscal 2025, the company now projects adjusted earnings in the range of $5.10 to $5.20 per share on organic sales growth of 7.5 to 8.0 percent or 6.0 to 7.0 percent when including COVID-19 testing-related sales.
Previously, the company e...